AstraZeneca Pharma India CFO Bhavana Agrawal Resigns Effective August 31, 2026
Bhavana Agrawal has resigned as Executive Director and Chief Financial Officer (CFO) of AstraZeneca Pharma India, effective August 31, 2026. Her resignation follows her appointment to a regional role within the AstraZeneca Group. The company confirmed there are no other material disclosures related to her departure. Agrawal does not hold shares in the company. AstraZeneca Pharma India reported a 22.95% decline in net profit for the quarter ending March 2026, while revenue increased by 20.42% year-on-year.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 37/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 21 Jul, 04:57 am. Other outlets followed.
- 1